News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
136,553 Results
Type
Article (4685)
Company Profile (96)
Press Release (131772)
Section
Business (44649)
Career Advice (208)
Deals (6820)
Drug Delivery (13)
Drug Development (18383)
Employer Resources (19)
FDA (1708)
Job Trends (2884)
News (70738)
Policy (4076)
Tag
Academia (300)
Alliances (12578)
Alzheimer's disease (276)
Approvals (1693)
Artificial intelligence (22)
Bankruptcy (37)
Best Places to Work (2311)
Biotechnology (89)
Breast cancer (36)
Cancer (275)
Career advice (196)
CAR-T (24)
Cell therapy (96)
Clinical research (14411)
Collaboration (127)
Compensation (37)
COVID-19 (441)
C-suite (47)
Cystic fibrosis (20)
Data (315)
Diabetes (23)
Diagnostics (764)
Drug discovery (25)
Earnings (12852)
Employer resources (19)
Events (24850)
Executive appointments (119)
FDA (1808)
Funding (99)
Gene therapy (45)
GLP-1 (100)
Government (361)
Healthcare (1753)
Infectious disease (457)
Inflammatory bowel disease (39)
Interviews (18)
IPO (3062)
Job creations (695)
Job search strategy (185)
Layoffs (33)
Legal (758)
Manufacturing (53)
Medical device (555)
Medtech (555)
Mergers & acquisitions (3835)
Metabolic disorders (67)
Neuroscience (340)
NextGen Class of 2024 (887)
Non-profit (269)
Northern California (472)
Obesity (37)
Opinion (37)
Parkinson's disease (19)
Patents (27)
People (16592)
Phase I (5632)
Phase II (6837)
Phase III (3633)
Pipeline (137)
Policy (22)
Postmarket research (249)
Preclinical (2416)
Press Release (51)
Radiopharmaceuticals (48)
Rare diseases (43)
Real estate (1536)
Regulatory (3133)
Research institute (314)
Resumes & cover letters (20)
Southern California (438)
Startups (1043)
United States (3711)
Vaccines (53)
Weight loss (18)
Date
Today (30)
Last 7 days (243)
Last 30 days (1074)
Last 365 days (9530)
2024 (8765)
2023 (10277)
2022 (13453)
2021 (13958)
2020 (10817)
2019 (7295)
2018 (5660)
2017 (6599)
2016 (6019)
2015 (7050)
2014 (5393)
2013 (4438)
2012 (4849)
2011 (5270)
2010 (4845)
Location
Africa (137)
Alabama (19)
Asia (8773)
Australia (2075)
California (1065)
Canada (363)
China (58)
Connecticut (34)
Europe (21983)
Florida (92)
Illinois (91)
Indiana (57)
Maryland (124)
Massachusetts (761)
Michigan (52)
Minnesota (65)
New Jersey (270)
New York (257)
North Carolina (185)
Northern California (472)
Ohio (26)
Pennsylvania (263)
South America (213)
Southern California (438)
Texas (116)
Washington State (219)
136,553 Results for "immatics biotechnologies gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immatics Announces Pricing of $150 Million Public Offering
October 11, 2024
·
3 min read
Press Releases
Immatics Announces Proposed $150 Million Public Offering
October 10, 2024
·
3 min read
Business
Immatics Announces First Quarter 2024 Financial Results and Business Update
Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, provided a business update and reported financial results for the quarter ended March 31, 2024.
May 14, 2024
·
20 min read
Press Releases
Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME
November 18, 2024
·
21 min read
Press Releases
Immatics Appoints Alise Reicin to Board of Directors
July 31, 2024
·
5 min read
Business
Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024
October 4, 2024
·
3 min read
Business
Immatics Announces Full Year 2023 Financial Results and Corporate Update
Immatics N.V. provided a business update and reported financial results for the quarter and full year ended December 31, 2023.
March 21, 2024
·
19 min read
Press Releases
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME
November 11, 2024
·
12 min read
Press Releases
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
September 6, 2024
·
2 min read
Deals
Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO
Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.
June 13, 2024
·
3 min read
1 of 13,656
Next
